Skip to content

A prospective randomized controlled study of Tongluo analgesic gel combined with extracorporeal shock wave in the treatment of plantar fasciitis based on three-dimensional gait analysis

A prospective randomized controlled study of Tongluo analgesic gel combined with extracorporeal shock wave in the treatment of plantar fasciitis based on three-dimensional gait analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000238
Enrollment
Unknown
Registered
2025-02-10
Start date
2025-02-12
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plantar fasciitis

Interventions

Control group:shock wave
Treatment group:Tongluo analgesic gel for topical use combined with shock wave

Sponsors

905 Hospital of the People's Liberation Army Navy
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Meets diagnostic criteria; Be between the ages of 18-70; No other methods or medications in the past 6 months; Exclude local space-occupying lesions such as tuberculosis infection or tumor of the foot and serious systemic diseases; Voluntarily participate in the study and cooperate with the doctor to complete sign the informed consent form.

Exclusion criteria

Exclusion criteria: Failure to meet the above diagnostic criteria; Accompanied by severe respiratory diseases hematopoietic system diseases cardiovascular and cerebrovascular diseases endocrine diseases etc.; presence of a psychiatric disorder; Those who are participating in other clinical trials or have participated in other clinical trials within 3 months; Those who are allergic to Chinese medicine or excipients in this gel; Those who are being treated with other oral or topical medications.

Design outcomes

Primary

MeasureTime frame
3D gait analysis;

Secondary

MeasureTime frame
VAS score;Plantar fascia thickness;Symptom grading quantitative scale score;

Countries

China

Contacts

Public ContactWang Meiling

905 Hospital of the People's Liberation Army Navy

goingplay@163.com13122211339

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026